Weekly shots aim to boost growth in kids with dwarfism

NCT ID NCT06433557

Summary

This 3-year study is testing whether a combination of two weekly injection drugs can safely help children with achondroplasia grow faster. It involves 22 children aged 2 to 11 and will measure their yearly growth rate and monitor for side effects. The goal is to see if using both drugs together works better than using one of them alone.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACHONDROPLASIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Ascendis Pharma Investigational Site

    Copenhagen, 2100, Denmark

  • Ascendis Pharma Investigational Site

    Dublin, D01 YC76, Ireland

  • Ascendis Pharma Investigational Site

    London, W1W 5AH, United Kingdom

Conditions

Explore the condition pages connected to this study.